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Abstract 
The aim of this review was to identify the psychometric properties and the appropriateness of the most frequently 
used measures of breathlessness to help the clinical health professionals and researchers to select the appropriate one 
in treating patients.   
A literature search was performed using EBSCO host, Ovid, Science Direct, and Springer Link databases. Eighteen 
measures of breathlessness were identified, five of them were unidimentional and thirteen were multidimensional 
breathlessness-specific measures. None of the measures were comprehensive or responsive enough to be 
recommended for use alone to measure breathlessness. It seems wise to integrate and validate the present measures 
rather than developing new ones. 
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1. Introduction 
The aim of this review was to identify the psychometric properties and the appropriateness of the most frequently used 
measures of breathlessness to help the clinical health professionals and researchers to select the appropriate one in 
treating patients. The breathlessness measures have been used in conditions such as chronic obstructive pulmonary 
disease (COPD), cancer, heart failure (HF), cystic fibrosis, motor neuron disease (MND), and end stage renal disease 
(ESRD). The findings of this paper shed light on the characteristics of these instruments which will help researchers in 
selecting the most appropriate one for their studies and clinical nurses in selecting the most appropriate one for 
assessing and treating their patients. 
Reviewing literature showed no consensus on one definition of breathlessness by researchers. Breathlessness is defined 
as “a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in 
intensity.
1
 The experience is derived from interaction among multiple physiological, psychological, social and 
environmental factors and may induce secondary physiological and behavioral responses” (p: 322).  However, experts 
agree that beathlessness has three main parts: physiological, functional, and psychological.
2
  
Breathlessness is affected by many factors such as past experiences, gender, tolerance to discomfort, cultural norms, 
and unique breathlessness Breathlessness is still difficult to measure, despite its wide prevalence in population. 
triggers.  
In the past few decades, the most of the instruments focused on the assessment of breathlessness only among 
hospitalized patients with chronic pulmonary diseases.
3
 Recently, the focus is more on the management of 
breathlessness than its assessment; thus, this requires valid, reliable, and sensitive assessment tools to measure this 
uncomfortable condition.  
2. Search method 
Nursing and health care journals published between 1960 and 2011 were reviewed using the keywords and synonyms 
in various combinations (Table 1). The online databases: EBSCOhost, Ovid, Science Direct, and Springer Link were 
searched. The selection criteria were research studies published in English and focusing on the development and 
validation of breathlessness instruments used with adult patients, and research studies used breathlessness instruments.  
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The search process results with five unidimentional scales, which measures the severity of “dyspnea” or 
“breathlessness” (both terms can be used interchangeably) and thirteen multidimensional breathlessness-specific tools 
were identified.  
 
3. Results 
3.1 Unidimentional tools   
The unidimentional tools are those that measure breathlessness on exercise or in general and often used to describe the 
severity of breathlessness. All of the unidimensional tools (Table 2) are self-administered and quick to complete, which 
include: 
 
3.1.1Visual analogue scale-dyspnea (VAS-D) 
The Visual analogue scales are one of the most popular measurement devices in nursing research and practice. Visual 
analogue scales are relatively easy to construct, administer, score and acceptance by respondents, even in the critical 
care environment. 
8
 Visual analogue scales tries to measure a characteristic or attitude that is believed to range across a 
continuum of values and cannot simply be measured directly such as breathlessness, pain, appetite. 
8
 The data are 
usually treated as being interval or ratio level.  
Visual analogue scale has several limitations. 
9
 First, photocopying the scale can cause small, systematic alterations in the 
length of the line; therefore, printing is preferable. Second, that is the participant’s tendency to place the marks at a 
similar position when scoring multiple VASs simultaneously. Third, it measures only one dimension of a phenomenon at 
a time and ignores other factors contributing to breathlessness. Forth, it is not suitable for comparing breathlessness in 
different patients because the sensation of breathlessness can differ between measures.
3
 Finally; there are no standardized 
criteria for use by different researchers.  
Visual analogue scale has moderate to strong reliability as assessed by test/retest method. 
9
 The validity of the VAS has 
been established in numerous studies as a measure of breathlessness and or other symptoms. A study on six male subjects 
with COPD rated both the sense of effort required to breathe and the degree of discomfort associated with breathing on a 
vertical VAS during exercise on a braked cycle. 
10
 The researchers tested the convergent validity of this scale and found 
that the VAS ratings of the sense of respiratory effort and discomfort were highly correlated in each subject (r = 0.99 ± 
0.006).
10
 
 
3.1.2 Oxygen cost diagram (OCD) 
The oxygen cost diagram is a variation of the VAS. However, few researchers reported some difficulties with patients’ 
lack of understanding of how to use it.
11
 In addition, OCD has limited use in patients who are breathless at rest because it 
relies profoundly on ambulatory activities. Significant correlation was found with distance walked in 12 minutes but not 
with one-second forced expiratory volume (FEV1); and moderate correlation between anxiety and depression (r = 0.68) 
and physical activities (r = -0.9).
12
   No sufficient information is available about the reliability of this scale.  
 
3.1.3 Numerical rating scale (NRS) 
Numerical rating scale is similar to VAS in the description and its limitations but it is easier and more frequently used 
than VAS.
13
 Unlike the VAS; both NRS and MBS can be used over the phone.
14
  
Numerical rating scale was used to measure both sensory and affective dimensions of breathlessness. No information 
available about the reliability of NRS. The validity for the Dyspnea-NRS was established with high correlation with 
VAS-D (r: 82).
15 
 
3.1.4 Modified Borg scale (MBS) 
Patients who used the Modified Borg scale and emergency department triage nurses and primary care nurses rated the 
MBS as highly satisfactory with its quick and easy to use and adequately expressed breathlessness. However, this 
scale has been criticized for its confusing words and instructions.
16
 Modified Borg scale is available in English, 
French, German, Japanese, Hebrew, and Russian languages.  
The MBS correlated well with other clinical parameters and could be useful when monitoring outcomes in patients 
with acute bronchospasm.
17
  The convergent validity of VAS and MBS scales was demonstrated with high 
correlation (r = 0.92, p = 0.001).
18 
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3.1.5 Verbal rating scale or SOB rating scale 
Verbal rating scale is simple and quick to use in a variety of clinical settings, it is the most widely used scale for 
the measurement of pain, requires no equipment and have consistently lower failure rates than the VAS.
19
 The 
use of verbal rating scale and its validation in the setting of breathlessness for the first time was supported in 
literature.
15
  The Verbal rating scale was validated in emergency department patients.
20
  The detection of 
between-subject variability provides information on a patient’s level of physiological distress and also helps 
quantify additional subjective psychosocial influences causative to perceived breathlessness severity. In this 
study the verbal dyspnea scores (VDS) at triage correlated significantly with RR (r = 0.77, p < 0.001), cutaneous 
oxygen saturation measurement (SaO2) (r = -0.43, p < 0.001), HR (r = 0.35, p < 0.001) and SBP (r = 0.19, p < 
0.05). The correlations remained significant after thirty minutes for RR (r = 0.74, p < 0.001), SaO2 (r = -0.39, p 
< 0.001) and HR (r = 0.40, p < 0.001).
35
 
All of the five mentioned tools are simple, easy to administer and score. However, no one of them is free from 
limitations. The only two tools which are valid and reliable and can rely on in acute conditions are VAS and 
MBS. Verbal rating scale may be better than VAS and the MBS because it can be administered to critically ill 
patients without burden, also it is easily used by illiterate patients but it needs further validation. Numerical 
rating scale and oxygen cost diagram have no information about their reliability. 
 
3.2 Multidimensional tools 
The multidimensional breathlessness measures assess the impact of breathlessness on more than one dimension 
such as emotional and mental functioning. Thirteen multidimensional breathlessness-specific tools (Table 3) 
were identified. All of  the multidimensional tools are used in research, and most of them were used in clinical 
settings, which include: 
 
3.2.1 Medical Research Council (MRC) dyspnea scale       
Medical Research Council dyspnea scale measures the effect of breathlessness on activities of daily living. 
MRC dyspnea scale is simple, can be self-administered or interviewer administered, takes 30 seconds for 
completion, and available in English language only. MRC dyspnea scale is not sensitive enough to detect small 
significant symptomatic changes following an intervention. 
20, 32
 
The convergent validity for MRC was established by the significantly correlated scores (r = 0.48- 0.70, p < 0.001) 
between MRC, OCD, and BDI.
11
 There is no data related to the reliability of MRC and modified MRC. 
The sensitivity and responsiveness of the MRC scale to the existence and treatment of laryngotracheal stenosis, and its 
correlation with objective measures of respiratory physiology was tested on 40 tracheostomy-free patients (16 males and 
24 females).
33
              Medical Research Council dyspnea scale was administered to all patients with 
laryngotracheal stenosis preoperatively and at the first visit to outpatient clinic after 4-6 weeks of operation. The higher 
the degree of airway obstruction before treatment, the higher scores of dyspnea (r = 0.75, p < .0001).
33
 This finding 
proves the discriminant validity of MRC dyspnea scale and its high sensitivity to the presence of varying degrees of 
laryngotracheal stenosis. 
  
3.2.2 Baseline Dyspnea Index (BDI) / Transition Dyspnea Index (TDI) 
Baseline Dyspnea Index /Transition Dyspnea Index has been widely used in clinical trials; it is translated into more than 
25 languages.
34
 The BDI/TDI is easily administered, it takes approximately three minutes to complete. Interview video 
tapes and written instructions are available about the BDI /TDI as guidance for the interviewer.
34
   
The BDI/TDI measure the severity of breathlessness by observer interviewer in three categories: functional impairment, 
magnitude of task, and magnitude of effort. Applying the two indexes, one at the baseline state and the second applied 
after intervention to measure the degrees of improvement or deterioration in breathing, this approach is better than 
applying a single-state scale repetitively for determining interval changes in breathlessness.
34
  
The BDI and TDI have been used extensively in populations with pulmonary diseases, and in clinical trials, and have 
been shown to correlate better with physiologic measures than other breathlessness scales.
11
 Recently; this index was 
used in patients with neuromuscular disease. The correlation coefficients were 0.98 for each category of the BDI and TDI, 
signifying nearly perfect reproducibility within patients.
35
   In a retrospective study on 88 male patients with COPD, it 
was found moderate to strong relationship between modified MRC, BDI, and OCD, and strong correlation between both 
BDI and OCD scores and arterial blood gases (ABGs) abnormalities.
36
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3.2.3 Breathlessness, Cough and Sputum Scale (BCSS) 
The Breathlessness, Cough and Sputum Scale is a brief, three-items, patient-reported outcome measure in which each of 
the three symptoms assessed by the measure is represented by a single item.
22
  In BCSS subjects are asked to assess and 
record the severity of three symptoms of COPD: breathlessness, cough, and sputum. The diary format of the BCSS 
enables investigators and clinicians to assess symptom changeability, including the variance associated with acute 
exacerbations, and to evaluate the pathway of symptom severity over time in this patient population. The symptoms of 
breathlessness, cough, and sputum have been identified as key symptoms of COPD in various statements, and are those 
most likely to be affected by pharmacotherapy designed to improve and control respiratory symptoms in this population. 
22
 
The items of BCSS and total scale scores were found to be internally consistent (Cronbach’s alpha = 0.70 
daily; 0.95 to 0.99 over time) and reproducible under stable conditions. 
38
 Intra-class correlation 
coefficients for item and total scores ranged from 0.74 to 0.78. Values for both indicators of reliability 
exceeded the guideline of 0.70 for group-level analyses. The breathlessness has small to moderate 
correlation with FEV1, peak expiratory flow (PEF), moderate correlation with Borg scale; total BCSS had 
low to moderate correlation with short form-36 (SF-36).
22 
 
3.2.4 Chronic lung disease (CLD) severity index 
The development of this index started by a comprehensive list of symptom items derived from the MRC questionnaire, 
the American Thoracic Society questionnaire, and others. The six CLD severity index items correlated significantly with 
all eight scales of the SF-36 (range of r from 0.19 to 0.37; p < 0.01). CLD severity index had significant correlations with 
the episodes of acute bronchitis (r = 0.28; p < 0.001), the number of inhalers (r = 0.16; p < 0.01), the use of oxygen (r = 
0.15; p < 0.01), and the number of outpatient visits (r = 0.16; p < 0.01).
23
 Thus, the CLD severity index is a reliable 
measure and is suitable for making group comparisons. The CLD validity is supported by its significant relationship with 
health-related quality of life (HRQoL), number of inhalers, use of oxygen, episodes of acute bronchitis, and number of 
outpatient visits. Compared with PEFR, the CLD index explained more of the variability in HRQoL as measured by 
SF-36.
23
 However; this index limits the ability to distinguish asthma from chronic bronchitis and/or emphysema as 
suggested by the American Thoracic Society.
23 
 
3.2.5 University of California San Diego (UCSD) Shortness of Breath Questionnaire (SOBQ) 
The existing UCSD SOBQ founded after numerous modifications of a previous questionnaire described in 
1987 by Archibald and Guidotti which measured shortness of breath during activities of daily living (ADL) 
in individuals with COPD.
39
 The psychometric properties of the UCSD SOBQ was assessed in 28 COPD 
patients, 9 with cystic fibrosis, and 17 post lung transplant patients, their age ranged from 12 to 82 years. 
All the participants were included in pulmonary rehabilitation program.
24
 The reliability was tested, the 
Cronbach’s α was 0.96, demonstrating excellent internal consistency, and item-total correlations ranged 
from 0.49 - 0.87. Additionally, patients completed both old and new versions of the UCSD SOBQ. The 
correlation between both versions was 0.96, representing good agreement. 
The validity was also tested within the same patients by comparing UCSD SOBQ scores with other measures.
24 
  Scores 
were negatively correlated with diffusion capacity (-0.67), predicted forced vital capacity (-0.36) and FEV in one second 
(-0.50), HRQoL (Quality of Well Being questionnaire -0.41), maximal inspiratory pressure (-0.60), and the 6-minute 
walk test (-0.68). Cronbach’s alpha for the SOBQ was 0.91 both at baseline and after-intervention.
24
 The UCSD SOBQ 
was used in a number of pulmonary rehabilitation studies, all of them publicized that it is reliable and valid when used 
among COPD and post lung transplant.
40
  
 
3.2.6 University of Cincinnati Dyspnoea Questionnaire (UCDQ) 
University of Cincinnati Dyspnoea Questionnaire had two formats; self-administered and experimenter-administered. 
Both format contained the same questions and take 5 to 10 minutes for completion. For the purpose of developing this 
questionnaire, it was administered to 203 subjects, their age ranged from 23 to 87 years; all of them had pulmonary 
diseases of various types (asthma, sarcoidosis, emphysema, fibrosis, or COPD).
25
  The internal consistency of the 
individual items in each of the three sections of the questionnaire (physical, speech, and a combination of the two) was 
assessed by using Cronbach’s alpha coefficient; the results were 0.92, 0.95, and 0.91 for the physical, speech, and 
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combination of the two variables, respectively.
25 
 
Correlation coefficients between UCDQ and spirometric parameters (FEV1, VC, FEV1/ VC %) were negative, weak to 
moderate, and significant only for physical and combined sections of the questionnaire. The Cronbach's alpha 
coefficients were 0.79, 0.96 and 0.82 for the physical, speech and combined variables, respectively. Correlation 
coefficients with blood gases (PaO2, PaCO2, and Sat of O2 %) and diffusion capacity (TL, CO, TL, CO/VA) parameters 
were statistically insignificant.
41
 
Construct validity has been verified between different sections of UCDQ and symptoms score (physical activity r = 0.60, 
p < 0.001; speech activity r = 0.35, p = 0.014; 
combined r = 0.63, p = 0.001), this means that patients who are clinically more affected will have poorer UCDQ scores. 
UCDQ correlates strongly with the classic dyspneic scales, 
BDI and MRC, these verify the concurrent validity of this complex questionnaire.
41 
 
3.2.7 Feinstein's Index of Dyspnea (FID)   
Feinstein's Index of Dyspnea is simple, easy to apply and takes only few moments for completion. The FID 
was primarily called Yale scale then modified by Feinstein in 1989.
26
  This index of breathlessness and 
fatigue has been applied to rate the condition of patients with congestive heart failure (CHF). The index 
helps reflect the quality of life (QoL) in patients with CHF; because breathlessness and fatigue are major 
symptoms and sources of clinical distress. In double-blind trials of therapy, the post therapeutic changes in 
the index ratings were significantly higher with lisinopril than with Captopril.
26 
 
3.2.8 Cancer dyspnoea scale (CDS) 
Cancer dyspnoea scale used mainly to measure breathlessness in cancer patients, it is validated in Japanese, English and 
Swedish population, completed in 2 minutes. The convergent validity with VAS is 0.72, and with Borg scales 0.67.
31
 The 
reliability of this scale was tested by Cronbach’s alpha (r = 0.86) and test retest reliability (r = 0.66). The criterion-related 
validity was demonstrated by significant group differences in CDS scores when patients were stratified by breathlessness 
intensity, as measured by VAS-D.
42
      
Correlations between the total CDS score and other breathlessness scales varied between 0.63 and 0.68. Convergent 
validity was shown by comparing the CDS-score subscales with conceptually related measures of physical and emotional 
function and discomfort, and the correlations ranged from 0.34 to 0.57. The CDS-S evaluated the psychological 
dimension of breathlessness better than did the VAS-D. Cronbach’s alpha coefficients were ranging from 0.81 to 0.90 
which reveals the internal consistency of the CDS-S. The CDS has two weaknesses; first, it asks patients to rate 
breathlessness by recalling which could be confusing to them, second, it is not helpful to rate clinical change caused by 
treatment.
42
  
 
3.2.9 Breathlessness Assessment Guide (BAG) 
Breathlessness Assessment Guide was developed for use in the clinical setting rather than as an outcome measure for 
research; it may be completed by any member of health care team. The content of this guide derived from a review of 
theoretical literature, and the research and experiential knowledge of a team of nurse researchers working in a nursing 
breathlessness intervention clinic. Sixty patients with lung cancers, who had finished chemotherapy or radiotherapy and 
were suffering from breathlessness, were included in the original study. The guide does not have any inbuilt 
psychometric properties and therefore no attempt was made to test this formally.
28 The
 guide was planned around the 
following areas: 1) Patient details and underlying pathology in relation to breathlessness. 2) The MRC current respiratory 
symptoms questions and breathlessness scale modified to include a category of ‘breathlessness at rest’. 3) Timing and 
incidence of breathlessness. 4) Vertical visual analogue scales to rate breathlessness over the last 24 h: when breathing 
has been at its best, worst and how much distress breathlessness causes. 5) Information to be recorded on triggers for 
breathlessness, strategies used to improve breathlessness, limitations forced by breathlessness and feelings engendered by 
breathlessness. And 6) Breathlessness management plan.
28
  
 
3.2.10 Dyspnea Exertion Scale (DES) 
This scale measures the magnitude of task that causes breathlessness. This scale has been validated for patients with 
cancer.
 43
 There are few studies used this scale. In addition, there is no available data about the validity and reliability of 
this scale. 
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3.2.11 Dyspnea Assessment Questionnaire (DAQ) 
This questionnaire asks patients to pick one word from each of the 16 categories that describe their breathlessness over 
the last 24 hours. This scale has been used with cancer patients only, and there is no sufficient data about the validity and 
reliability of this scale.
 43
  
 
3.2.12 Dyspnea Management Questionnaire (DMQ) 
The content of "Dyspnea Management Questionnaire" was drawn from qualitative interview data, literature review, and 
pilot testing with three adults with COPD. The content validity of the DMQ was supported by a panel of 12 experts.
30
 
The internal consistency tested by Cronbach’s alpha coefficients ranging from .87 to .96 and test-retest reliability over 
2.5 weeks (intraclass correlation coefficient ranging from 0.71 to 0.95. Three subscales of DMQ-30; Dyspnea intensity, 
dyspnea-related anxiety, and fearful activity avoidance subscales of DMQ-30 were moderately to highly correlated with 
three Seattle Obstructive Lung Disease Questionnaire dimensions (r = 0.44-0.83), Medical Outcomes Study 12-Item 
Short-Form scales (r = 0.41-0.57), and Hospital Anxiety and Depression Scale-Anxiety (r = 0.59 to 0.65). While the other 
two subscales; self-efficacy for activity and satisfaction with strategy use were correlated mildly with Seattle Obstructive 
Lung Disease Questionnaire (r = 0.28 and 0.27, respectively). The DMQ can discriminate adults with COPD requiring 
supplemental oxygen from those not requiring it. The Dyspnea Management Questionnaire increase the insights into the 
benefit of psychoeducation, controlled breathing strategies, and cognitive-behavioral approaches in pulmonary 
rehabilitation for anxious patients with COPD.
30
  
 
3.2.13 Computer Adaptive Test (CAT)  
The Computer Adaptive Test tool can measure dyspnea by administering on average 10 questions for each participant; 
then, the selection of the following question depends on the person’s answer to the previous question.
31
 The questions are 
drawn from 44 items in item bank. All the items focusing on dyspnea, the selection of items uses an item response 
theory-based method for multiple questionnaires and organizes them on a common scale. The respondent continued in 
answering the questions until a prespecified maximum number of questions have been answered (5 to 15) or a specified 
standard error is reached (0.3). This method takes less time and has more precision than paper and pencil tests. The 
internal consistency reliability coefficient as tested by Cronbach’s alpha was 0.98. The item-total correlations ranged 
from 0.43 (eating) to 0.82 (going out socially) with a median of 0.72. The concurrent validity of the dyspnea item bank 
score was established by examining the correlation with the 6-minute walk distance and the overall shortness of breath 
question.  
The overall shortness of breath question was strongly correlated with the dyspnea item bank score (r = 0.76, p < .001). 
Thus, approximately 58% of the variance in the dyspnea item bank score was explained by the single shortness of breath 
item. Dyspnea score was a significant predictor of hospitalization at 1 or 3 months in logistic regression models (p 
< .05).
31
 The CAT can be administered by different modalities such as a computer, a voice-activated telephone, and a 
web-based system. The answers scored in real-time and results may be presented immediately. 
  
4. Discussion 
This review demonstrated that many instruments are available to measure breathlessness, varies from structured 
interviews to numeric scales. In addition, breathlessness may be measured in different settings, such as emergency units, 
doctors’ clinics, rehabilitation programs, and pulmonary function and exercise laboratories. In addition, it demonstrated 
the suitability of these tools to all adult age group. 
Considering the complexity of the symptom and the diverse approaches to measurement, the choice of breathlessness 
measures should be appropriate for the specific purpose of the study. None of the currently available instruments for 
breathlessness measurement was developed in the context of a theoretical and physiological model of breathlessness 
except CAT.  
The review identified five unidimensional scales and thirteen multidimensional tools. Only two unidimensional scale 
(VAS, MBS) and three of multidimensional tools (BDI/TDI, UCDQ, and CDS) met the criteria of validity, reliability, 
responsiveness and appropriateness. Three measures missing psychometric data, in one it had not been tested 
(Breathlessness assessment guide) and for others the data are not available (Dyspnea exertion scale and Dyspnea 
assessment questionnaire). For Computer Adaptive Test, the psychometric prosperities tested only one time because it is 
newly used for dyspneic patients. For Dyspnea Management Questionnaire it is minimally used in research and clinical 
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settings. 
Most of the scales and questionnaires included in this review have been evaluated in chronic respiratory disease, yet 
breathlessness is also common in advanced cancer, heart failure, and renal failure. None of the identified scales has been 
validated in renal failure patients and in palliative care setting and five of them used with cancer patients (CDS, 
Breathlessness assessment guide, Dyspnea exertion scale, Dyspnea assessment questionnaire, VAS) but only two of them 
are valid and reliable (CDS, VAS). Only four instruments applied with heart failure; two of them have no information 
related to their reliability (Feinstein’s Index of dyspnea, Numerical rating scale, CAT) only two of them valid and reliable 
(VAS, CAT). Thus, there is a lack of instruments that could apply to a group of breathless patients with different 
conditions. This makes research into a mixed patient group challenging with regard to the choice of the measurement 
tool. 
Other major findings were the inconsistencies in number of items, content and wording of the multidimensional tools. 
The variation in wordings of items is likely to affect the results. The number of items ranged from 3 to 44, the content of 
most tools asks about the magnitude of task that causes breathlessness, functional impairment, psychological aspects 
such as fear and anxiety, only one instrument reflect on the impact of breathlessness on speech (UCDQ). Unfortunately, 
the instrument that covers most aspects and dimensions of breathlessness, the Breathlessness Assessment Guide, has not 
undergone the usual psychometric testing examining the validity and reliability of the tool. Overall, the findings indicate 
that there is little agreement on how breathlessness should be assessed and what should be included. However, there is a 
consistency in the time required to complete the tools, the time required ranged from few seconds to few minutes which 
is acceptable for all patients. 
 
5. Conclusion 
 
Although 18 tools for assessing breathlessness were identified, none were comprehensive or responsive enough to be 
recommended for use in isolation to measure breathlessness and its impact on the QoL of patients and their families. All 
individuals having dyspnea related to advance diseases should be assessed appropriately. If the focus is more on QoL, 
then a multidimensional tool is preferable. It seems wise to spend time on integrating and validating the present scales 
rather than developing new ones 
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Table 1. Keywords and synonyms used in database search 
Breathlessness synonyms Major diseases and breathlessness Measures synonyms 
Breathlessness  
Dyspnea 
Shortness of breathing 
Chronic obstructive pulmonary disease  
Heart failure 
Motor neuron disease 
End stage renal disease  
cystic fibrosis 
cancer 
Asthma 
Measure 
Instrument 
Rating  scales 
Assessment tool  
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Table 2. Unidimensional breathlessness-specific instruments 
No Name of the 
scale 
Author/ Year Domains 
covered 
Population Format 
1- Visual 
analogue scale 
(VAS) 
Aitken in 
1969 
Dyspnea COPD, 
CHF, 
cancer 
VAS is usually a horizontal line, but it may be drawn also 
vertically, 100 mm in length, anchored by word descriptors 
(extreme states) at each end (Wewers & Lowe, 1990). 
2- Numerical 
rating scale 
(NRS) 
Gift & 
Narsavage in 
1998 
Dyspnea COPD, 
CHF 
Written form (tested) or verbal (needs to be validated); 
Anchor of 0 means no dyspnea intensity and dyspnea 
distress and anchor 10 means the worst possible 
breathlessness intensity and breathlessness distress.  
3- Modified Borg 
Scale (MBS) 
Borg in 1982 Dyspnea 
on 
exercise 
Pulmonary 
disease 
Categorical scale with ratio properties, 11 points on a 
vertical scale with words describing increasing degrees of 
breathlessness anchored to numbers between ‘0’ (‘nothing at 
all’) and ‘10’ (‘maximal’) 
4- Oxygen Cost 
Diagram 
(OCD) 
McGavin and 
co-workers in 
1978  
 
Dyspnea 
on 
exercise 
Pulmonary 
disease 
Retrospective measure. 100 mm vertical line with 
descriptive phrases of 13 everyday activities placed at 
various points along the line. Patients indicate the point 
above which they think their breathlessness would not let 
them go; usually further explanation necessary to understand 
the relationship between the vertical line and the listed 
activities. The phrases correspond with the oxygen 
requirements needed by each activity  
5- Verbal rating 
scale also 
called SOB 
rating scale 
Gift and 
Narsavage in 
1998 
Dyspnea COPD The line drawn with numbers or calibrations from 1 to 10 
can be placed at equal intervals below it. Usually treated as 
being at least interval level. 
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Table 3. Multidimensional breathlessness-specific instruments for adult population 
No Name of the 
scale 
Author/ 
Year 
Domains covered No. of 
items 
Population Format 
1- Medical 
Research 
Council (MRC) 
dyspnea scale 
Fletcher and 
co-workers 
in 1959 
magnitude of task 
that causes 
breathlessness 
5 COPD It is a categorical scale, 5 
point (1 = I only get 
breathless with strenuous 
exercise to 5 = I am too 
breathless to leave the 
house) with yes/no answers. 
It can be self-report or 
interview guide scoring the 
effect of breathlessness on 
daily activities;  
The modified MRC consists 
of six questions about 
perceived breathlessness: 
category 0 (no 
breathlessness), category 1 
(slight degree of 
breathlessness), category 2 
(moderate degree of 
breathlessness), category 3 
(moderately severe degree 
of breathlessness), category 
4 (severe degree of 
breathlessness), category 5 
(very severe degree of 
breathlessness)  
2- Baseline 
Dyspnea Index 
(BDI)/ 
Transition 
Dyspnea Index 
(TDI) 
Mahler and 
co-workers 
in 1984 
magnitude of task, 
magnitude of effort 
and functional 
impairment 
3 respiratory 
disease 
(predominantly 
COPD), 
amyotrophic 
lateral sclerosis 
(ALS) 
The BDI is used at baseline 
to assess breathlessness, it 
is interviewer administered; 
five grades for each 
category of breathlessness 
ranging from severe to 
unimpaired, BDI focal 
score is obtained by adding 
the scores from 0 (severe) 
to 4 (not impaired) for each 
of the three categories, the 
total score ranged from 0 to 
Journal of Natural Sciences Research                                                     www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.2, No.8, 2012 
 
 
12 
12.TDI used to measure 
changes from a baseline 
condition after intervention 
through ratings obtained on 
a 7-point scale (-3 = major 
deterioration to +3). 
3- Breathlessness, 
Cough and 
Sputum Scale 
(BCSS) 
Leidy and 
co-workers 
in 2003 
Symptoms 
(breathlessness, 
cough, sputum)  
3 COPD (FEV1 
predicted 
20-70%) 
It is a 5-point-Likert scale 
(0 to 4), higher scores 
demonstrating a more 
severe manifestation of the 
symptom. A daily total 
score is expressed as the 
sum of three item scores as 
stated in daily diary, with a 
range of 0 to 12.  
4- Chronic lung 
disease (CLD) 
severity index 
Selim and 
co-workers 
1997 
dyspnea, wheezing, 
and productive 
cough 
6 Severe chronic 
lung disease, 
bronchitis, 
emphysema, 
asthma), only 
men 
It is an interview 
instrument. It scored in two 
steps, first, sum the raw 
scores of the items included 
in the three subscales, then 
transform the raw scores of 
the items to a normal range 
from 0 (least severe) to100 
(most severe) (Selim et al, 
1997). 
5- University of 
California 
St.Diego 
(UCSD) 
Shortness of 
Breath 
Questionnaire 
Eakin and 
co-workers 
1998 
ADL, fear of 
overexertion, 
shortness of breath 
24 COPD, cystic 
fibrosis, post 
transplant 
It measures the severity of 
breathlessness over a 
variety of daily activities. 
It’s scored as 0= not at all to 
5= maximal or unable to do 
because of breathlessness; 
sum of scores ranged from 
0 to 120, the higher scores 
representing more severe 
breathlessness.  
 
6- University of 
Cincinnati 
Dyspnoea 
Questionnaire 
Lee and 
co-workers 
in 1997 
breathlessness 
during physical 
activity, during 
speaking activity, 
30 COPD, 
emphysema, 
fibrosis, 
sarcoidosis, 
Breathlessness is rating on 
5-point-scale (1= no 
shortness of breath, 5= 
activities always causing 
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when speaking 
during physical 
activity 
asthma  shortness of breath). It may 
be self-administered or 
experimenter administered 
with same questions.  
7- Feinstein's Index 
of Dyspnea 
Mahler and 
co-workers 
in 1984 
modified by 
Feinstein in 
1989. 
magnitude of task 
evoking dyspnea and 
fatigue, magnitude 
of pace (effort), 
associated functional 
impairment 
3 congestive heart 
failure  
Its content derived from 
BDI/TID, it consists from 3 
components, each rated on 
a scale from 0 (worst 
condition) to 4 (no 
breathlessness) completed 
by health professionals. 
Total score ranged from 0 to 
12.  
8- Cancer dyspnoea 
scale (CDS)  
Tanaka and 
co-workers 
in 2000 
sense of effort, sense 
of anxiety, sense of 
discomfort 
12 cancer This questionnaire consists 
of three factors; the 
physical factor called sense 
of effort (five items), a 
psychological factor called 
sense of anxiety (four 
items), and a factor 
reflecting the 
uncomfortable feeling at 
rest called sense of 
discomfort (three 
items).The maximum total 
score is 48, a higher score 
reflects more severe 
breathlessness (Tanaka et 
al, 2000). 
9- Breathlessness 
Assessment 
Guide  
Corner & 
O’Driscoll 
in 1999 
underlying 
pathology, 
symptoms, adapted 
MRC dyspnea scale, 
breathlessness 
frequency, timing, 
triggers, coping 
strategies, 
limitations, feelings, 
3 breathlessness 
VAS over last 24 h 
9 lung cancer It consists from 2 questions 
adapted from MRC 
respiratory symptoms 
questionnaire and dyspnea 
scale, and VAS. It is 
interviewer administered.   
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(best, worst, distress) 
10- Dyspnea 
Exertion Scale  
 magnitude of task 
that causes 
breathlessness 
5 cancer - 
11- Dyspnea 
Assessment 
Questionnaire  
Zeppet and 
co-workers 
in 1997 
intensity, temporal, 
constrictive pressure, 
pain, sound quantity, 
dry sound, wet 
sound, energy, air 
quantity, respiratory 
effort, loss of power, 
fear, depression, 
dread, suffocation, 
illness 
16 cancer  This questionnaire masures 
the intensity, temporal, 
constrictive pressure, pain, 
sound quantity, dry sound, 
wet sound, energy, air 
quantity, respiratory effort, 
loss of power, fear, 
depression, dread, 
suffocation, and illness 
12- Dyspnea 
Management 
Questionnaire 
Norweg and 
co-workers 
in 2006 
Dyspnea intensity, 
dyspnea-related 
anxiety, fearful 
activity avoidance, 
self-efficacy for 
activity, satisfaction 
with strategy use. 
30 COPD It has a 7-point Likert-type 
scale from 0 (cannot do 
because of shortness of 
breath) to 6 (not at all short 
of breath). The higher the 
score reflecting the better 
functional status of the 
client. Each item was 
assigned a numerical value 
from 0 to 6. In each 
subscale all values are 
summed then divided by the 
number of items in the 
subscale to obtain the mean 
score. 
13- Computer 
Adaptive Test  
Ruo and 
co-workers 
in 2010 
breathlessness 
during physical 
activity 
10 
questions 
Heart Failure The patients answer round 
10 questions of 44 items 
included in item bank. The 
dyspnea item bank scores 
range from approximately 
25 to 90 with higher scores 
representing dyspnea with 
less physical exertion. 
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